Role of abnormal microRNA expression in Helicobacter pylori associated gastric cancer

References

• Amieva MR, El-Omar EM. 2008. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology. 134:306–323.
   PubMed Web of Science ®Google Scholar
• Ando T, Yoshida T, Enomoto S, Asada K, Tatematsu M, Ichinose M, Sugiyama T, Ushijima T. 2009. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer. 124:2367–2374.
   PubMed Web of Science ®Google Scholar
• Backert S, Clyne M. 2011. Pathogenesis of Helicobacter pylori infection. Helicobacter 16(1):19–25.
   PubMedGoogle Scholar
• Backert S, Tegtmeyer N, Selbach M. 2010. The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter. 15:163–176.
   PubMed Web of Science ®Google Scholar
• Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297.
   PubMed Web of Science ®Google Scholar
• Battisti A, Morici P, Ghetti F, Sgarbossa A. 2017. Spectroscopic characterization and fluorescence imaging of Helicobacter pylori endogenous porphyrins. Biophys Chem. 229:19–24.
   PubMed Web of Science ®Google Scholar
• Baud J, Varon C, Chabas S, Chambonnier L, Darfeuille F, Staedel C. 2013. Helicobacter pylori initiates a mesenchymal transition through ZEB1 in gastric epithelial cells. PLoS One. 8:e60315.
   PubMedGoogle Scholar
• Belair C, Baud J, Chabas S, Sharma CM, Vogel J, Staedel C, Darfeuille F. 2011. Helicobacter pylori interferes with an embryonic stem cell micro RNA cluster to block cell cycle progression. Silence. 2:7.
   PubMedGoogle Scholar
• Belair C, Darfeuille F, Staedel C. 2009. Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship. Clin Microbiol Infect. 15:806–812.
   PubMed Web of Science ®Google Scholar
• Berge C, Terradot L. 2017. Structural insights into Helicobacter pylori Cag protein interactions with host cell factors. Curr Top Microbiol Immunol. 400:129–147.
   PubMed Web of Science ®Google Scholar
• Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Grønbaek K, Federspiel B, Lund AH, Friis-Hansen L. 2011. MiR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer. 10:29.
   PubMed Web of Science ®Google Scholar
• Butcher LD, den Hartog G, Ernst PB, Crowe SE. 2017. Oxidative stress resulting from Helicobacter pylori infection contributes to gastric carcinogenesis. Cell Mol Gastroenterol Hepatol. 3:316–322.
   PubMed Web of Science ®Google Scholar
• Chang H, Kim N, Park JH, Nam RH, Choi YJ, Lee HS, Yoon H, Shin CM, Park YS, Kim JM, et al. 2015. Different microRNA expression levels in gastric cancer depending on Helicobacter pylori infection. Gut Liver. 9:188–196.
   PubMed Web of Science ®Google Scholar
• Chmiela M, Karwowska Z, Gonciarz W, Allushi B, Stączek P. 2017. Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol. 23:1521–1540.
   PubMed Web of Science ®Google Scholar
• Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z, Chun-Sheng K. 2010. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer. 10:367.
   PubMed Web of Science ®Google Scholar
• Correa P, Houghton J. 2007. Carcinogenesis of Helicobacter pylori. Gastroenterology. 133:659–672.
   PubMed Web of Science ®Google Scholar
• de Souza CRT, Almeida MCA, Khayat AS, da Silva EL, Soares PC, Chaves LC, Burbano RMR. 2018. Association between Helicobacter pylori, Epstein-Barr virus, human papillomavirus and gastric adenocarcinomas. World J Gastroenterol. 24:4928–4938.
   PubMed Web of Science ®Google Scholar
• Douraghi M, Talebkhan Y, Zeraati H, Ebrahimzadeh F, Nahvijoo A, Morakabati A, Ghafarpour M, Esmaili M, Bababeik M, Oghalaie A, et al. 2009. Multiple gene status in Helicobacter pylori strains and risk of gastric cancer development. Digestion. 80:200–207.
   PubMed Web of Science ®Google Scholar
• Eischen CM, Lozano G. 2014. The Mdm network and its regulation of p53 activities: a rheostat of cancer risk. Hum Mutat. 35:728–737.
   PubMed Web of Science ®Google Scholar
• Fahimi F, Tohidkia MR, Fouladi M, Aghabeygi R, Samadi N, Omidi Y. 2017. Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy. Bioimpacts. 7:59–71.
   PubMed Web of Science ®Google Scholar
• Fassan MSD, Balsamo L, Cascione L, Castoro C, Coati I, De Bernard M, Farinati F, Guzzardo V, Valeri N, Zambon CF. 2016. Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis. Oncotarget. 7:4915–4924.
   PubMedGoogle Scholar
• Fassi Fehri L, Koch M, Belogolova E, Khalil H, Bolz C, Kalali B, Mollenkopf HJ, Beigier-Bompadre M, Karlas A, Schneider T, et al. 2010. Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner. PLoS One. 5:e9500.
   PubMed Web of Science ®Google Scholar
• Feeley KP, Adams CM, Mitra R, Eischen CM. 2017. Mdm2 is required for survival and growth of p53-deficient cancer cells. Cancer Res. 77:3823–3833.
   PubMed Web of Science ®Google Scholar
• Feng Y, Wang L, Zeng J, Shen L, Liang X, Yu H, Liu S, Liu Z, Sun Y, Li W, et al. 2013. FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370. Mol Cancer Res. 11:834–844.
   PubMed Web of Science ®Google Scholar
• Fernandes JV, Cobucci RN, Jatoba CA, Fernandes TA, de Azevedo JW, de AJM. 2015. The role of the mediators of inflammation in cancer development. Pathol Oncol Res. 21:527–534.
   PubMed Web of Science ®Google Scholar
• Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, et al. 2015. The global burden of cancer 2013. JAMA oncol. 1:505–527.
   PubMed Web of Science ®Google Scholar
• Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H. 2010. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer. 116:41–49.
   PubMed Web of Science ®Google Scholar
• Geng Y, Lu X, Wu X, Xue L, Wang X, Xu J. 2016. MicroRNA-27b suppresses Helicobacter pylori-induced gastric tumorigenesis through negatively regulating Frizzled7. Oncol Rep. 35:2441–2450.
   PubMed Web of Science ®Google Scholar
• Gobert AP, Wilson KT. 2017. Human and Helicobacter pylori interactions determine the outcome of gastric diseases. Curr Top Microbiol Immunol. 400:27–52.
   PubMed Web of Science ®Google Scholar
• Gong YH, Sun LP, Jin SG, Yuan Y. 2010. Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7241 subjects from China. Eur J Clin Microbiol Infect Dis. 29:907–911.
   PubMed Web of Science ®Google Scholar
• Gu L, Liu L, Zhong L, Bai Y, Sui H, Wei X, Zhang W, Huang P, Gao D, Kong Y. 2014. Cthrc1 overexpression is an independent prognostic marker in gastric cancer. Hum Pathol. 45:1031–1038.
   PubMed Web of Science ®Google Scholar
• Guo JQ, Li SJ, Guo GX. 2017. Long noncoding RNA AFAP1-AS1 promotes cell proliferation and apoptosis of gastric cancer cells via PTEN/p-AKT pathway. Dig Dis Sci. 62:2004–2010.
   PubMed Web of Science ®Google Scholar
• Hatakeyama M. 2017. Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Jpn Acad Ser B Phys Biol Sci. 93:196–219.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Tsujii M, Wang J, Kondo J, Akasaka T, Jin Y, Li W, Nakamura T, Nishida T, Iijima H, et al. 2013. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut. 62:1536–1546.
   PubMed Web of Science ®Google Scholar
• He C, Chen M, Liu J, Yuan Y. 2014. Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis. Mutat Res Rev Mutat Res. 759:14–26.
   PubMed Web of Science ®Google Scholar
• Huang L, Wang ZY, Pan DD. 2018. Penicillin-binding protein 1A mutation positive Helicobacter pylori promotes epithelial-mesenchymal transition in gastric cancer via the suppression of microRNA134. Int J Oncol. 54:916–928.
   PubMed Web of Science ®Google Scholar
• Ishiguro H, Kimura M, Takeyama H. 2014. Role of microRNAs in gastric cancer. World J Gastroenterol. 20:5694–5699.
   PubMed Web of Science ®Google Scholar
• Ishimoto T, Izumi D, Watanabe M, Yoshida N, Hidaka K, Miyake K, Sugihara H, Sawayama H, Imamura Y, Iwatsuki M, et al. 2015. Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa. J Gastroenterol. 50:751–757.
   PubMed Web of Science ®Google Scholar
• Kalisperati P, Spanou E, Pateras IS, Korkolopoulou P, Varvarigou A, Karavokyros I, Gorgoulis VG, Vlachoyiannopoulos PG, Sougioultzis S. 2017. Inflammation, DNA damage, Helicobacter pylori and gastric tumorigenesis. Front Genet. 8:20.
   PubMed Web of Science ®Google Scholar
• Kaparakis M, Walduck AK, Price JD, Pedersen JS, van Rooijen N, Pearse MJ, Wijburg OL, Strugnell RA. 2008. Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice. Infect Immun. 76:2235–2239.
   PubMed Web of Science ®Google Scholar
• Karimi Kurdistani Z, Saberi S, Tsai K-W, Mohammadi M. 2015. MicroRNA-21: mechanisms of oncogenesis and its application in diagnosis and prognosis of gastric cancer. Arch Iran Med. 18:524–536.
   PubMed Web of Science ®Google Scholar
• Kiga K, Mimuro H, Suzuki M, Shinozaki-Ushiku A, Kobayashi T, Sanada T, Kim M, Ogawa M, Iwasaki YW, Kayo H, et al. 2014. Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic infection. Nat Commun. 5:4497.
   PubMed Web of Science ®Google Scholar
• Koch M, Mollenkopf HJ, Klemm U, Meyer TF. 2012. Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis. Proc Natl Acad Sci USA.109:E1153–E1162.
   PubMed Web of Science ®Google Scholar
• Lee J, Ha S, Jung CK, Lee HH. 2015. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition. Int J Oncol. 46:2431–2438.
   PubMed Web of Science ®Google Scholar
• Li Q, Liu J, Gong Y, Yuan Y. 2016. Serum VacA antibody is associated with risks of peptic ulcer and gastric cancer: a meta-analysis. Microb Pathog. 99:220–228.
   PubMed Web of Science ®Google Scholar
• Li P, Shan JX, Chen XH, Zhang D, Su LP, Huang XY, Yu BQ, Zhi QM, Li CL, Wang YQ, et al. 2015. Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment. Cell Res. 25:588–603.
   PubMed Web of Science ®Google Scholar
• Li N, Tang B, Zhu ED, Li BS, Zhuang Y, Yu S, Lu DS, Zou QM, Xiao B, Mao XH. 2012. Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett. 586:722–728.
   PubMed Web of Science ®Google Scholar
• Lim JH, Kim SG, Choi JM, Yang HJ, Kim JS, Jung HC. 2018. Helicobacter pylori is associated with miR-133a expression through promoter methylation in gastric carcinogenesis. Gut Liver.12:58–66.
   PubMed Web of Science ®Google Scholar
• Liu W, Song N, Yao H, Zhao L, Liu H, Li G. 2015. miR-221 and miR-222 simultaneously target RECK and regulate growth and invasion of gastric cancer cells. Med Sci Monit. 21:2718–2725.
   PubMed Web of Science ®Google Scholar
• Ma X, Becker Buscaglia LE, Barker JR, Li Y. 2011. MicroRNAs in NF- B signaling. J Mol Cell Biol. 3:159–166.
   PubMed Web of Science ®Google Scholar
• Ma L, Chen Y, Zhang B, Liu G. 2014. Increased microRNA-223 in Helicobacter pylori-associated gastric cancer contributed to cancer cell proliferation and migration. Biosci Biotechnol Biochem. 78:602–608.
   PubMed Web of Science ®Google Scholar
• Ma MZ, Zhuang C, Yang XM, Zhang ZZ, Ma H, Zhang WM, You H, Qin W, Gu J, Yang S, et al. 2014. CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt/PCP-Rho signaling. Neoplasia. 16:265–278.
   PubMed Web of Science ®Google Scholar
• Miao L, Liu K, Xie M, Xing Y, Xi T. 2014. miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signaling. Cancer Immunol Immunother. 63:699–711.
   PubMed Web of Science ®Google Scholar
• Miftahussurur M, Yamaoka Y, Graham DY. 2017. Helicobacter pylori as an oncogenic pathogen, revisited. Expert Rev Mol Med. 19:e4.
   PubMed Web of Science ®Google Scholar
• Nardone G, Martin G, Rocco A, Rippa E, La Monica G, Caruso F, Arcari P. 2008. Molecular expression of Gastrokine 1 in normal mucosa and in Helicobacter pylori-related preneoplastic and neoplastic gastric lesions. Cancer Biol Ther. 7:1890–1895.
   PubMed Web of Science ®Google Scholar
• Noto JM, Piazuelo MB, Chaturvedi R, Bartel CA, Thatcher EJ, Delgado A, Romero-Gallo J, Wilson KT, Correa P, Patton JG, et al. 2013. Strain-specific suppression of microRNA-320 by carcinogenic promotes expression of the antiapoptotic protein Mcl-1. Am J Physiol Gastrointest Liver Physiol. 305:G786–G796.
   PubMed Web of Science ®Google Scholar
• Oertli M, Engler DB, Kohler E, Koch M, Meyer TF, Muller A. 2011. MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis. J Immunol.187:3578–3586.
   PubMed Web of Science ®Google Scholar
• Oertli M, Noben M, Engler DB, Semper RP, Reuter S, Maxeiner J, Gerhard M, Taube C, Muller A. 2013. Helicobacter pylori gamma-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance. Proc Natl Acad Sci USA. 110:3047–3052.
   PubMed Web of Science ®Google Scholar
• Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Ishizuka T, Arisawa T, Hirata I. 2010. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter. 15:524–531.
   PubMed Web of Science ®Google Scholar
• Piletic K, Kunej T. 2016. MicroRNA epigenetic signatures in human disease. Arch Toxicol. 90:2405–2419.
   PubMed Web of Science ®Google Scholar
• Polakovicova I, Jerez S, Wichmann IA, Sandoval BA, Carrasco VN, Corvalan AH. 2018. Role of microRNAs and exosomes in Helicobacter pylori and Epstein-Barr virus associated gastric cancers. Front Microbiol. 9:636.
   PubMed Web of Science ®Google Scholar
• Qu Y, Dang S, Hou P. 2013. Gene methylation in gastric cancer. Clin Chim Acta. 424:53–65.
   PubMed Web of Science ®Google Scholar
• Qu M, Li L, Zheng WC. 2017. Reduced miR-490-3p expression is associated with poor prognosis of Helicobacter pylori induced gastric cancer. Eur Rev Med Pharmacol Sci. 21:3384–3388.
   PubMed Web of Science ®Google Scholar
• Rana TM. 2007. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol. 8:23–36.
   PubMed Web of Science ®Google Scholar
• Rossi AF, Cadamuro AC, Biselli-Perico JM, Leite KR, Severino FE, Reis PP, Cordeiro JA, Silva AE. 2016. Interaction between inflammatory mediators and miRNAs in Helicobacter pylori infection. Cell Microbiol. 18:1444–1458.
   PubMed Web of Science ®Google Scholar
• Salama NR, Hartung ML, Muller A. 2013. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 11:385–399.
   PubMed Web of Science ®Google Scholar
• Santos JC, Brianti MT, Almeida VR, Ortega MM, Fischer W, Haas R, Matheu A, Ribeiro ML. 2017. Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway. Mol Carcinog. 56:1372–1379.
   PubMed Web of Science ®Google Scholar
• Schneider BG, Piazuelo MB, Sicinschi LA, Mera R, Peng D-F, Roa JC, Romero-Gallo J, Delgado AG, de Sablet T, Bravo LE, et al. 2013. Virulence of infecting Helicobacter pylori strains and intensity of mononuclear cell infiltration are associated with levels of DNA hypermethylation in gastric mucosae. Epigenetics. 8:1153–1161.
   PubMed Web of Science ®Google Scholar
• Shafiee M, Aleyasin SA, Mowla SJ, Vasei M, Yazdanparast SA. 2016. The effect of microRNA-375 overexpression, an inhibitor of Helicobacter pylori-induced carcinogenesis, on lncRNA SOX2OT. Jundishapur J Microbiol. 9:e23464.
   PubMed Web of Science ®Google Scholar
• Shao L, Chen Z, Soutto M, Zhu S, Lu H, Romero-Gallo J, Peek R, Zhang S, El-Rifai W. 2019. Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer. FASEB J. 33:264–274.
   Google Scholar
• Shen J, Xiao Z, Wu WKK, Wang MH, To KF, Chen Y, Yang W, Li MSM, Shin VY, Tong JH, et al. 2015. Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis. Cancer Res. 75:754–765.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Chiba T, Marusawa H. 2017. Helicobacter pylori-mediated genetic instability and gastric carcinogenesis. Curr Top Microbiol Immunol. 400:305–323.
   PubMed Web of Science ®Google Scholar
• Sokolova O, Naumann M. 2017. NF-kappaB signaling in gastric cancer. Toxins (Basel). 9:114.
   Web of Science ®Google Scholar
• Stubljar D, Jukic T, Ihan A. 2018. How far are we from vaccination against Helicobacter pylori infection? Expert Rev Vaccines. 17:935–945.
   PubMed Web of Science ®Google Scholar
• Sun F, Ni Y, Zhu H, Fang J, Wang H, Xia J, Ding F, Shen H, Shao S. 2018. microRNA-29a-3p, up-regulated in human gastric cells and tissues with H.Pylori infection, promotes the migration of GES-1 cells via A20-mediated EMT pathway. Cell Physiol Biochem. 51:1250–1263.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H, Nagai S, Koyasu S, Gilman RH, Kersulyte D, et al. 2009. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe. 5:23–34.
   PubMed Web of Science ®Google Scholar
• Szkaradkiewicz A, Karpiński TM, Majewski J, Malinowska K, Goślińska-Kuźniarek O, Linke K. 2015. The participation of p53 and bcl-2 proteins in gastric carcinomas associated with Helicobacter pylori and/or Epstein-Barr virus (EBV). Pol J Microbiol. 64:211–216.
   PubMed Web of Science ®Google Scholar
• Talebi Bezmin Abadi A, Lee YY. 2016. Chinese Helicobacter pylori vaccine: solution for an old challenge? World J Gastrointest Pharmacol Ther7:412–415.
   PubMedGoogle Scholar
• Tegtmeyer N, Neddermann M, Asche CI, Backert S. 2017. Subversion of host kinases: a key network in cellular signaling hijacked by Helicobacter pylori CagA. Mol Microbiol. 105:358–372.
   PubMed Web of Science ®Google Scholar
• Teng GG, Wang WH, Dai Y, Wang SJ, Chu YX, Li J. 2013. Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Toll-like receptor 4. PLoS One. 8:e56709.
   PubMed Web of Science ®Google Scholar
• Tsai MMHH, Wang CS, Lee KF, Tsai CY, Lu PH, Chi HC, Lin YH, Kuo LM, Lin KH. 2016. MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer. Oncotarget. 7:39511–39526.
   PubMedGoogle Scholar
• Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. 2001. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 345:784–789.
   PubMed Web of Science ®Google Scholar
• Valenzuela MA, Canales J, Corvalan AH, Quest AF. 2015. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. World J Gastroenterol. 21:12742–12756.
   PubMed Web of Science ®Google Scholar
• Wan J, Xia L, Xu W, Lu N. 2016. Expression and function of miR-155 in diseases of the gastrointestinal tract. Int J Mol Sci. 17:709.
   Web of Science ®Google Scholar
• Wang W, Luo HS, Yu BP. 2004. Expression of NF-kappaB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions. World J Gastroenterol. 10:177–181.
   PubMed Web of Science ®Google Scholar
• Wang FLJ, Zou Y, Jiao Y, Huang Y, Fan L, Li X, Yu H, He C, Wei W, Wang H, et al. 2017. MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2. Oncotarget. 8:28711–28724.
   PubMedGoogle Scholar
• Wu K, Yang L, Li C, Zhu C-H, Wang X, Yao Y, Jia Y-J. 2014. MicroRNA-146a enhances Helicobacter pylori induced cell apoptosis in human gastric cancer epithelial cells. Asian Pac J Cancer P. 15:5583–5586.
   PubMedGoogle Scholar
• Wu WK, Yu J, Chan MT, To KF, Cheng AS. 2016. Combinatorial epigenetic deregulation by Helicobacter pylori and Epstein-Barr virus infections in gastric tumourigenesis. J Pathol. 239:245–249.
   PubMed Web of Science ®Google Scholar
• Xiao B, Zhu E-D, Li N, Lu D-S, Li W, Li B-S, Zhao Y-L, Mao X-H, Guo G, Yu P-W, Zou Q-M. 2012. Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol Rep. 27:559–566.
   PubMed Web of Science ®Google Scholar
• Xu XC, Zhang WB, Li CX, Gao H, Pei Q, Cao BW, He TH. 2019. Up-regulation of miR-1915 inhibits proliferation, invasion, and migration of Helicobacter pylori-infected gastric cancer cells via targeting RAGE. Yonsei Med J. 60:38–47.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li X, Du J, Yin Y, Li Y. 2018. Involvement of microRNAs-MMPs-E-cadherin in the migration and invasion of gastric cancer cells infected with Helicobacter pylori. Exp Cell Res. 367:196–204.
   PubMed Web of Science ®Google Scholar
• Yang L, Li C, Jia Y. 2018. MicroRNA-99b promotes Helicobacter pylori-induced autophagyand suppresses carcinogenesis by targeting mTOR. Oncol Lett. 16:5355–5360.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Si RH, Liang YH, Ma BQ, Jiang ZB, Wang B, Gao P. 2016. Mir-30d increases intracellular survival of Helicobacter pylori through inhibition of autophagy pathway. World J Gastroenterol. 22:3978–3991.
   PubMed Web of Science ®Google Scholar
• Yasmin R, Siraj S, Hassan A, Khan AR, Abbasi R, Ahmad N. 2015. Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies. Mediators Inflamm. 2015:201703.
   PubMed Web of Science ®Google Scholar
• Ye F, Tang C, Shi W, Qian J, Xiao S, Gu M, Dang Y, Liu J, Chen Y, Shi R, et al. 2015. A MDM2-dependent positive-feedback loop is involved in inhibition of miR-375 and miR-106b induced by Helicobacter pylori lipopolysaccharide. Int J Cancer. 136:2120–2131.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Choi YJ, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS. 2013. GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle. Clin Cancer Res. 19:4599–4610.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Choi YJ, Choi WS, Nam SW, Lee JY, Park WS. 2013. Functional analysis of the NH2-terminal hydrophobic region and BRICHOS domain of GKN1. Biochem Biophys Res Commun. 440:689–695.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Seo HS, Choi SS, Chae HS, Choi WS, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS. 2014. Gastrokine 1 inhibits the carcinogenic potentials of Helicobacter pylori CagA. Carcinogenesis. 35:2619–2629.
   PubMed Web of Science ®Google Scholar
• Yu J, Feng J, Zhi X, Tang J, Li Z, Xu Y, Yang L, Hu Z, Xu Z. 2015. Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer. Tumour Biol. 36:3221–3229.
   PubMedGoogle Scholar
• Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, Xiao S, Lu H. 2008. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest. 88:1358–1366.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Zhang PY, Aboul-Soud MA. 2017. From inflammation to gastric cancer: role of Helicobacter pylori. Oncol lett. 13:543–548.
   PubMed Web of Science ®Google Scholar
• Zhao X-D, Lu Y-Y, Guo H, Xie H-H, He L-J, Shen G-F, Zhou J-F, Li T, Hu S-J, Zhou L, et al. 2015. MicroRNA-7/NF-kappaB signaling regulatory feedback circuit regulates gastric carcinogenesis. J Cell Biol. 210:613–627.
   PubMed Web of Science ®Google Scholar
• Zhou X, Chen H, Zhu L, Hao B, Zhang W, Hua J, Gu H, Jin W, Zhang G. 2016. Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c. Oncotarget. 7:82770–82782.
   PubMedGoogle Scholar
• Zhou X, Li L, Su J, Zhang G. 2014a. Decreased miR-204 in H. pylori-associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4. PLoS One. 9:e101457.
   PubMed Web of Science ®Google Scholar
• Zhou X, Su J, Zhu L, Zhang G. 2014b. Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression. Helicobacter. 19:174–181.
   PubMed Web of Science ®Google Scholar
• Zhou X, Xia Y, Li L, Zhang G. 2015. MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2. Cancer Biol Ther. 16:160–169.
   PubMed Web of Science ®Google Scholar
• Zhou X, Xia Y, Su J, Zhang G. 2014d. Down-regulation of miR-141 induced by helicobacter pylori promotes the invasion of gastric cancer by targeting STAT4. Cell Physiol Biochem. 33:1003–1012.
   PubMed Web of Science ®Google Scholar
• Zhou X, Xu G, Yin C, Jin W, Zhang G. 2014c. Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK. Oncotarget. 5:11631–11640.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Jiang Q, Lou X, Ji X, Wen Z, Wu J, Tao H, Jiang T, He W, Wang C, et al. 2012. MicroRNAs up-regulated by CagA of Helicobacter pylori induce intestinal metaplasia of gastric epithelial cells. PLoS One. 7:e35147.
   PubMed Web of Science ®Google Scholar
• Zou M, Wang F, Jiang A, Xia A, Kong S, Gong C, Zhu M, Zhou X, Zhu J, Zhu W, et al. 2017. MicroRNA-3178 ameliorates inflammation and gastric carcinogenesis promoted by Helicobacter pylori new toxin, Tip-alpha, by targeting TRAF3. Helicobacter. 22:1–14.
   Google Scholar